| 11766431 |
Therapeutical composition containing apomorphine as active ingredient |
Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett |
2023-09-26 |
| RE49444 |
Method of treating osteoporosis comprising administration of PTHrP analog |
Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle, Zhengxin Dong |
2023-03-07 |
| 11026938 |
Therapeutical composition containing apomorphine as active ingredient |
Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett |
2021-06-08 |
| 8748382 |
Method of drug delivery for bone anabolic protein |
Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle |
2014-06-10 |
| 8148333 |
Stable composition comprising a PTHrP analogue |
Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle |
2012-04-03 |
| 7803770 |
Method of treating osteoporosis comprising administration of PTHrP analog |
Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle |
2010-09-28 |
| 5209933 |
Long acting calcium channel blocker composition |
Calum B. MacFarlane, Alastair B. Selkirk, John Langridge |
1993-05-11 |
| 5198226 |
Long acting nicardipine hydrochloride formulation |
Calum B. MacFarlane, Alastair B. Selkirk |
1993-03-30 |
| 5164405 |
Nicardipine pharmaceutical composition for parenteral administration |
Calum B. McFarlane, Alistair Selkirk |
1992-11-17 |
| 5063220 |
Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl )piperazine |
Alastair B. Selkirk |
1991-11-05 |
| 4973591 |
Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl )piperazine |
Alastair B. Selkirk |
1990-11-27 |
| 4940556 |
Method of preparing long acting formulation |
Calum B. MacFarlane, Alastair B. Selkirk |
1990-07-10 |